JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway

Published:2023-02 Issue: Volume:115 Page:109693
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Lu Yaru,Ma Qian,Yu Lu,Huang Huan,Liu Xiaoxi,Chen Pei,Ran Hao,Liu Weibin^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference52 articles.

1. Myasthenia Gravis;Gilhus;N Engl J Med.,2016

2. Myasthenia gravis

3. Myasthenia gravis: the role of complement at the neuromuscular junction;Howard;Ann N Y Acad Sci.,2018

4. Complement and myasthenia gravis;Sanderson;Mol Immunol.,2022

5. Complement associated pathogenic mechanisms in myasthenia gravis;Tüzün;Autoimmun Rev.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing ARL11 relieved atherosclerotic inflammation and lipid deposition via retraining JAK2/STAT1 pathway;Atherosclerosis;2024-09

2. Repositioning of baricitinib for management of memory impairment in ovariectomized/D-galactose treated rats: A potential role of JAK2/STAT3-PI3K/AKT/mTOR signaling pathway;Life Sciences;2024-08

3. Baricitinib as a treatment for myasthenia gravis: a case report;Neuromuscular Disorders;2024-08

4. Unfolding the Role of Th17 Cells in Neutrophilic Lung Inflammation;American Journal of Respiratory Cell and Molecular Biology;2024-08

5. Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives;Pharmaceutics;2024-05-11